Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2010
03/25/2010WO2010007085A3 Use of gcn5 inhibitors in medicine
03/25/2010WO2010006200A3 Triggered release of drugs from polymer particles
03/25/2010WO2009155489A3 Compositions and methods for treating influenza
03/25/2010WO2009155257A8 Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers
03/25/2010WO2009151288A3 Oligopeptide for enhancing osteointegration and osteogenesis
03/25/2010WO2009149191A3 Methods of treating inflammatory intestinal disease and managing symptoms thereof
03/25/2010WO2009141264A3 Gallidermin to treat infections of the respiratory tract
03/25/2010WO2009111083A3 In vivo temporal control of activ at able matrix- degrading enzymes
03/25/2010WO2009099679A3 Treatment of disease conditions via administration of dna repair enzyme
03/25/2010WO2009074793A3 Methods for the inhibition of scarring
03/25/2010WO2009018010A9 Methods for the treatment or prevention of hemorrhagic conditions
03/25/2010WO2008140594A3 Peptide nanoparticles and uses therefor
03/25/2010WO2008095004A3 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
03/25/2010US20100077508 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077507 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077496 MO-1, A Gene Associated With Morbid Obesity
03/25/2010US20100077492 Oxidative DNA Damage Protection
03/25/2010US20100076489 Wound closure material
03/25/2010US20100076465 Fibrin-based nerve repair conduit and method of producing the same
03/25/2010US20100076184 Gbs toxin receptor
03/25/2010US20100076175 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
03/25/2010US20100076174 ErbB Interface Peptidomimetics And Methods Of Use Thereof
03/25/2010US20100076067 Biodegradable block copolymeric compositions for drug delivery
03/25/2010US20100076063 Genetic modification of targeted regions of the cardiac conduction system
03/25/2010US20100076008 Pharmaceutical compositions containing plasma protein
03/25/2010US20100075911 Dimeric iap inhibitors
03/25/2010US20100075910 Synthetic peptide amides and dimeric forms thereof
03/25/2010US20100075909 Peptide
03/25/2010US20100075908 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
03/25/2010US20100075907 Neuromedin u receptor agonists and uses thereof
03/25/2010US20100075906 Targeted Therapeutic Proteins
03/25/2010US20100075905 Novel cellular factor-containing solution compositions
03/25/2010US20100075904 Carbon nanotube composite scaffolds for bone tissue engineering
03/25/2010US20100075903 Stable ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist suitable for intravitreal administration to the eye
03/25/2010US20100075902 Recombinant XRGD-Enriched Gelatins Having High Stability
03/25/2010US20100075901 Novel use of hiv nc protein
03/25/2010US20100075900 Use of Nutritional Compositions for Preventing Disorders
03/25/2010US20100075899 Targeted photodynamic therapy agent
03/25/2010US20100075898 N-terminal vdac variants and uses thereof
03/25/2010US20100075897 Method for sustainedly releasing bioactive peptides and application thereof
03/25/2010US20100075896 Repair of larynx, trachea, and other fibrocartilaginous tissues
03/25/2010US20100075895 Cyclic Natriuretic Peptide Constructs
03/25/2010US20100075894 Reducing er stress in the treatment of obesity and diabetes
03/25/2010US20100075893 Preparation of a pharmaceutical composition for increasing bone mineral density
03/25/2010US20100075892 Inhibition of SKP2-Cyclin a Interaction
03/25/2010US20100075891 Novel polynucleotides encoding polypeptides and methods using same
03/25/2010US20100075402 DNA coding for polypeptide fusion
03/25/2010US20100075342 Biomarker for ovarian cancer CTAP3-related proteins
03/25/2010US20100074961 purifying protein-containing-polyethylene glycol-microspheres using a supercritical fluid
03/25/2010US20100074959 Lipid growth factor formulations
03/25/2010US20100074958 Methods and compositions for targeting fenestrated vasculature
03/25/2010US20100074946 Process for preparing purified nucleic acid and the use thereof
03/25/2010US20100074945 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes
03/25/2010US20100074940 Linear polyesteramides from aminophenolic esters
03/25/2010US20100074936 Repair of larynx, trachea, and other fibrocartilaginous tissues
03/25/2010US20100074935 Recombinant lubricin molecules and uses thereof
03/25/2010US20100074933 Cell And Enzyme Compositions For Modulating Bile Acids, Cholesterol and Triglycerides
03/25/2010US20100074913 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
03/25/2010US20100074912 Hila-a24-binding kef-derived peptide
03/25/2010US20100074910 Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment
03/25/2010US20100074907 Methods for Promoting Myelination, Neuronal Survival and Oligodendrocyte Differentiation Via Administration of SP35 or TrkA Antagonists
03/25/2010US20100074905 Methods for soluble zalpha11 cytokine receptors
03/25/2010US20100074904 Specific activation of a regulatory t cell and its use for treatment of asthma, allergic disease, autoimmune disease, graft rejection and for tolerance induction
03/25/2010US20100074899 Methods for treating conditions associated with masp-2 dependent complement activation
03/25/2010US20100074898 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors
03/25/2010US20100074891 Sclerostin and the inhibition of Wnt signaling and bone formation
03/25/2010US20100074889 4'-allene-substituted nucleoside derivatives
03/25/2010US20100074888 Animal having modification in mgat2 gene
03/25/2010US20100074887 Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases
03/25/2010US20100074886 Ccr2 antagonists for treatment of fibrosis
03/25/2010US20100074884 Inhibition of neuronal damage
03/25/2010US20100074883 implantable device for providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue; medical equipment
03/25/2010US20100074882 Methods and compositions for preserving the viability of photoreceptor cells
03/25/2010US20100074881 Multiple nebulizer systems
03/25/2010US20100074880 Polyethylene glycol derivative
03/25/2010US20100074879 Skin agent for external use and cosmetic agent including ubiquinone derivative or salt thereof and method using the same
03/25/2010US20100074876 Calcium phosphate delivery vehicles for osteoinductive proteins
03/25/2010US20100074869 Multifunctional Cytokines
03/25/2010US20100074868 Controlled Release Compositions for Interferon Based on PEGT/PBT Block Copolymers
03/25/2010US20100074867 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
03/25/2010US20100074866 Interferon alpha mutant and its polyethylene glycol derivative
03/25/2010US20100074865 Formulations of peg-interferon alpha conjugates
03/25/2010US20100074864 Methods and kits for predicting prognosis of multiple sclerosis
03/25/2010US20100074863 Anti-infective pyrrolidine derivatives and analogs
03/25/2010US20100074862 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
03/25/2010US20100074861 Compounds having a cyclic moiety and compositions for delivering active agents
03/25/2010US20100074857 Compositions and methods to treat epithelial-related conditions
03/25/2010DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms
03/25/2010CA2737921A1 Methods for preparing purified polypeptide compositions
03/25/2010CA2737920A1 Peptidomimetic macrocycles
03/25/2010CA2737918A1 Peptidomimetic macrocycles
03/25/2010CA2737914A1 Peptidomimetic macrocycles
03/25/2010CA2737835A1 Synergistic combinations of a macrocyclic inhibitor of hcv and a nucleoside
03/25/2010CA2737828A1 Intestinal treatment
03/25/2010CA2737774A1 Methods, systems, and compositions for calpain inhibition
03/25/2010CA2737771A1 Whey and thymus function
03/25/2010CA2737770A1 Process for the synthesis of (aib8,35)hglp-1(7-36)-nh2
03/25/2010CA2737756A1 Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
03/25/2010CA2737619A1 Nutritional support of the immune system during anti-cancer treatment
03/25/2010CA2737614A1 Inhibiting interaction between hif-1.alpha. and p300/cbp with hydrogen bond surrogate-based helices
1 ... 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 ... 3163